The waist-to-hip ratio (WHR) is one of the most commonly used anthropometric measures to indicate a central obesity pattern and an increased risk of cardiovascular disease in normal-weight women. Although the American Heart Association has reported that a WHR > 0.80 be used to indicate increased risk of cardiovascular disease in women, the present study assessed the WHR above which is seen elevations in cardiovascular disease risk factors in a sample of overweight women. Using data from 240 women aged 27.5-47.5 y enrolled in a university weight-loss program, we determined WHR quartiles: < 0.80, 0.80 to < 0.84, 0.84 to < 0.90, and ≥ 0.90. Subjects were placed into high-risk categories for cardiovascular disease on the basis of age-and population-defined norms. Women had an increased likelihood of elevated VLDL cholesterol, triacylglycerol, diastolic blood pressure, and composite risk (ie, having ≥ 4 cardiovascular disease risk factors) and an increased risk of having low concentrations of HDL at a WHR ≥ 0.90. All aforementioned variables had a significant odds ratio at a WHR ≥ 0.90 after adjustment for smoking, whereas elevated VLDL, triacylglycerol, and diastolic blood pressure were observed at this WHR after adjustment for a body mass index (in kg/m 2 ) < or ≥ 35. Only 2 variables, VLDL and triacylglycerol, had a significant odds ratio at a WHR < 0.90 before and after adjustment for BMI and smoking. These data suggest an upward shift in the critical threshold for WHR to ≥ 0.90, at which point there was an elevation in cardiovascular disease risk factors in already overweight women. This trend persisted regardless of whether the women smoked or whether their body mass index was < or ≥ 35.
INTRODUCTION
Past research has shown consistently that adipose tissue distribution, rather than absolute total fat, is associated with risk of diabetes (1, 2) , hypertension (1, 3) , hyperlipidemia (4, 5) , and coronary artery disease (CAD) (6, 7) . At least one large cohort study showed a 60% greater relative risk of death in women with a more centralized pattern of fat distribution (8) . Because the waist-to-hip ratio (WHR) is the most commonly used index of central fat distribution (9) , its use may be beneficial in routine monitoring and assessment of overweight patients who may be at increased risk of CAD.
The current recommendation by the American Heart Association (10) is to reduce the WHR to < 0.80, the criterion used to indicate a pattern of central obesity and an increased risk of CAD in adult women (10) (11) (12) . Additional research has provided evidence that a WHR of 0.80-0.85 is associated with subsequent increased risk of CAD, morbidity, and mortality (7, 13) . These studies, however, were generally conducted on large heterogeneous populations in terms of both body mass index (BMI) and body weight. It may be important to examine an overweight population independently because this group of individuals may present a different set of metabolic and physiologic sequelae relative to their BMI and body weight, which would affect their CAD risk.
Total obesity is a risk factor for CAD (14, 15) and the distribution of fat in an obese population in relation to other cardiovascular disease risk factors may be different from that of the general population. Therefore, the general recommendation to reduce the WHR to < 0.80 may not be appropriate for all individuals. The purpose of this study was to examine further the relation between WHR and cardiovascular disease risk factors in an overweight, premenopausal population to determine the WHR at or above which there is an increased likelihood of having elevated cardiovascular disease risk factors.
SUBJECTS AND METHODS

Subjects
Medical records from subjects entering a weight-loss program between 1990 and 1993 were abstracted. All subjects had to be premenopausal and not taking exogenous hormones. Subjects
Clinical predictability of the waist-to-hip ratio in assessment of cardiovascular disease risk factors in overweight, premenopausal women 1,2 who were taking medications that would affect serum lipoproteins, blood pressure (BP), or carbohydrate metabolism were excluded from the analysis. A total of 240 premenopausal women aged 18-54 y were included in the final data collection and analysis: 110 white (45.8%), 90 African American (37.5%), and 40 Hispanic (16.6%) women. The protocol was approved by the Office of Research Standards at the University of Miami.
Methods
Baseline measurements were obtained after an overnight fast. Information on current smoking and drinking habits was also obtained. Subjects were weighed on a balance scale while barefooted and their height was measured with a wall-mounted ruler. BMI was calculated by dividing weight (kg) by height squared (m). Waist circumference was measured with a Gulick II springloaded measuring tape (Gay Mills, WI) midway between the inferior angle of the ribs and the suprailiac crest, whereas hip circumference was measured at the outermost points of the greater trochanters (16) . WHR was recorded to the nearest 2 decimal places. Because 2 investigators performed all the anthropometric measurements, an intraclass correlation coefficient was calculated: 0.96 for waist circumference and 0.94 for hip circumference.
BP was taken by trained personnel using a mercury sphygmomanometer and stethoscope. Measurements were taken from the left upper arm after subjects had been sitting for ≥ 5 min in accordance with the recommendation of the American Heart Association (17) . Duplicate measurements were taken with a 5-min rest interval between measurements and the mean value was recorded to the nearest 2.0 mm Hg.
Blood specimens were obtained in 10-mL, silica-coated, self-separating tubes (Fisher Scientific, Fair Lawn, NJ) and analyzed by the Lipid Research Clinics Laboratory after an overnight fast. Serum lipids were measured according to a standardized protocol reported by the Lipid Research Clinic (18) . Assays for this study were conducted by the Centers for Disease Control and Prevention laboratory in Miami, which also ensured calibration.
The total cholesterol concentration was measured spectrophotometrically after several enzymatic steps and was read at a wavelength of 500 nm. The cholesterol content of HDLs was measured in the supernatant fraction of serum after removal of LDLs and VLDLs by precipitation with heparin and manganese chloride (18, 19) . In another analysis in which serum lipoproteins were separated by ultracentrifugation, VLDLs were removed by precipitation. A separate aliquot was prepared that contained both LDLs and HDLs in serum. Total and HDL cholesterol in serum were measured according to the procedures stated above and LDL was calculated by subtracting HDL from total cholesterol (18) . VLDL was obtained by subtracting the sum of LDL and HDL from total cholesterol. Triacylglycerol concentrations were determined enzymatically after treatment of blood with lipase and measurement of glycerol release (20) .
Identification of high-risk categories
Subjects were placed in high-risk categories if any serum lipoprotein concentration, except HDL, was at or above the 75th percentile of population-based norms according to third National Health and Nutrition Examination Survey data (21) . For HDL cholesterol, subjects were placed in the high-risk category if values were at or below the 25th percentile of population-based norms according to third National Health and Nutrition Examination Survey data. Participants were placed in the high-risk category for systolic (SBP) and diastolic (DBP) BP if values fell at or above levels defined as clinically hypertensive (22) . Subjects were also placed into the high-risk category if their fasting glucose concentrations were ≥ 6.1 mmol/L (110 mg/dL), placing them at risk of impaired glucose intolerance (23) . A composite risk category containing all the aforementioned variables was created to indicate a clustering of risk factors. If subjects were in ≥ 50% of the high-risk categories for all measured cardiovascular disease risk factors, they were assigned to the composite risk category.
Statistical analysis
All statistical analyses were conducted by using SAS software (24) . To determine the extent to which the WHR was associated with cardiovascular disease risk factors, overweight women were divided into quartiles based on their WHR at the time of enrollment into the weight-loss program: quartile 1, < 0.80; quartile 2, 0.80 to < 0.84; quartile 3, 0.84 to < 0.90; and quartile 4, ≥ 0.90. Analysis of variance (ANOVA) was performed to determine whether there were any significant differences in the physical characteristics and cardiovascular disease risk factors among the 4 quartiles. If there was a significant main effect, Tukey's post hoc test was performed to determine how the groups differed. Age-adjusted odds ratios were determined by the incidence of being placed in a particular high-risk category for any serum lipid concentration, glucose concentration, BP value, or composite risk group, divided by the incidence of not being placed in the high-risk category. Because the average woman has a WHR < 0.80 (25) and because a WHR < 0.80 is considered optimal (indicative of minimal CAD risk) (10), women with a WHR < 0.8 were used as the reference group. The Mantel-Haenszel extension test was performed to assess the overall trend of an increasing WHR quartile associated with an increasing likelihood of being classified as high risk.
A series of stratified analyses were also examined separately for BMI, smoking history, and alcohol consumption. A BMI ≥ 35 has been used to identify women with high risk of CAD and all-cause mortality (13) . Thus, subjects were stratified into 2 groups according to whether their BMI was < or ≥ 35. A chisquare analysis was performed to determine differences in the proportion of smokers, drinkers, and women with a BMI < or ≥ 35 across the 4 WHR quartiles. Additionally, age-adjusted odds ratios were calculated for overweight women after they were stratified according to whether their BMI was < or ≥ 35. A total of 110 women had a BMI ≥ 35. Subjects were also classified as smokers or nonsmokers on the basis of their verbal responses to questions regarding the daily number of cigarettes smoked. These verbal responses were used to perform an ageadjusted odds ratio stratified according to smoking status. A total of 116 respondents reported smoking an average of 1.1 packs/d. Alcohol consumption was determined by verbal responses to questions regarding the type (wine, spirits, or beer) and amount (in g) of alcohol consumed weekly. Of those individuals who reported drinking regularly, most drank weekly. Total alcohol intake was recorded as the sum of wine, spirits, and beer consumption and was calculated on the assumption that half a pint of beer or lager contains Ϸ9 g alcohol, a glass of wine contains 10 g, and a measure of spirits contains 8 g. Of those individuals who reported drinking weekly, the average person consumed Ϸ13 g alcohol/wk.
RESULTS
Characteristics of the subjects are presented in Table 1 . There were significant differences among the 4 WHR quartiles for mean body weight, BMI, and waist circumference. Quartile 4 had a significantly greater body weight and BMI than quartile 1 and a significantly greater waist circumference than all other quartiles. For the entire sample, age was significantly, but weakly, correlated with waist circumference (r = 0.16, P < 0.05) but not with WHR. A chi-square analysis performed on the total sample showed no significant differences in the racial or ethnic composition across quartiles ( 2 = 5.17, P = 0.16). Results of a chi-square analysis of the distribution of smokers, drinkers, and women with a BMI ≥ 35 are shown in Table 2 . The chi-square analysis was significant for each of the aforementioned variables; thus, pairwise chi-square comparisons were performed. There was a significantly lower percentage of smokers in quartile 1 than in quartile 2 (P < 0.05). There was also a significantly lower percentage of drinkers in quartile 4 than in quartiles 1 and 3 (P < 0.05). In addition, the distribution of women with a BMI ≥ 35 was greater in quartile 4 than in quartiles 1 and 2 (P < 0.001). The distribution of women with a BMI ≥ 35 was similar in quartiles 3 and 4.
On the basis of the results shown in Table 3 , subjects represented an apparently healthy group of overweight women. In quartile 4 only, mean total cholesterol concentrations were > 5.2 mmol/L (200 mg/dL), the concentration considered acceptable by the National Institutes of Health (21), indicating that most women had total cholesterol concentrations within an appropriate range. Mean HDL concentrations were > 1.29 mmol/L (50 mg/dL) for each quartile, further indicating that most women were healthy and had an adequate concentration of the cardioprotective lipoprotein (26) , which is consistent with the fact that none of the subjects were prescribed medicines to alter serum lipoproteins or BP. There were significant differences among the 4 quartiles for all cardiovascular disease risk factors except total and LDL cholesterol. Quartile 4 had significantly higher VLDL, triacylglycerol, and DBP values than all other quartiles. Quartiles 3 and 4 had significantly lower HDL concentrations than quartile 1. Quartile 4 had significantly higher total:HDL cholesterol and fasting glucose values than quartile 1 only and significantly higher SBP than quartiles 1 and 3 (P < 0.05).
Age-adjusted odds ratios and CIs for serum lipoproteins, SBP, DBP, and composite risk of quartiles 2, 3, and 4, relative to quartile 1, are shown in Table 4 . Odds ratios for having a higher DBP and composite risk and lower HDL were greatest in quartile 4. The odds of having elevated serum triacylglycerol and VLDLs were 4.49 and 6.71 times greater, respectively, in quartile 4 than in quartile 1. Furthermore, all variables evidenced a significant test for trend (P < 0.01). Because so few women had fasting glucose concentrations ≥ 6.1 mmol/L, indicative of impaired glucose tolerance (23), this variable was excluded from the odds ratio analysis.
To determine whether the pattern observed in the age-adjusted odds ratios would be maintained after potential confounders were controlled for, we stratified each analysis separately on the basis of alcohol intake, BMI, and smoking status. In the stratified analysis for alcohol, the pattern of significant findings for the odds ratios in Table 4 did not change for any variable.
The effects of adjusting for BMI (< 35 or ≥ 35) on serum lipoproteins, SBP, DBP, and composite risk are presented in Table 5 . As in the unstratified analysis, there was a significant odds ratio for DBP in quartile 4 after BMI was stratified for. There was also a trend toward a significant odds ratio for both HDL and composite risk in the same quartile; however, for both variables the 95% CI marginally exceeded the lower limit for a significant 95% CI of 1.0 (1.01 and 1.02 for HDL and composite risk, respectively) and was subsequently rounded off to 1.0. As with the unstratified analysis, the odds of having elevated serum VLDLs and triacylglycerols were greater in quartiles 3 and 4 than in quartile 1. Lastly, all aforementioned variables evidenced a significant test for trend. 2 Indicates differences among means across the 4 quartiles (ANOVA).
TABLE 2
Chi-square analysis of the distribution of smokers, drinkers, and subjects with a BMI ≥ 35 by waist-to-hip ratio quartile The effects of adjusting for smoking status are shown in Table 6 . As in the unstratified analysis, the odds of having reduced HDLs and elevated DBP and composite risk were greater in quartile 4 than in quartile 1. All aforementioned variables showed a significant test for trend. Therefore, the results of the stratified analysis almost paralleled those of the unstratified analysis. Note that stratification of the sample by either BMI or smoking status reduced the overall statistical power, which may partially explain why HDL and composite risk no longer had significant odds ratios in quartile 4 after adjustment for BMI.
DISCUSSION
In the present study, a WHR ≥ 0.90 was associated with elevated VLDL, triacylglycerol, DBP, and composite risk values and reduced HDL concentrations, all of which are ominous indicators of CAD risk (27) (28) (29) (30) (31) . It can be argued that the women in quartile 4 had increased values for these cardiovascular disease risk factors because they generally had a BMI ≥ 35. However, our chi-square analysis showed that the distribution of women with a BMI ≥ 35 was similar between quartiles 3 and 4. Therefore, the greater likelihood of being placed into a high-risk category for several cardiovascular disease risk factors in women with a WHR ≥ 0.90 cannot be fully explained by their having a BMI ≥ 35. Even after our results were stratified by BMI, they indicated a significant odds ratio for VLDL, triacylglycerol, and DBP in quartile 4. This was somewhat unexpected because a higher BMI has been shown to be associated with substantial increases in CAD risk and all-cause mortality (13) . Thus, our findings provide some speculation that a higher BMI is not solely responsible for increases in cardiovascular disease risk factors.
There is a substantial body of research indicating that regional fat distribution is associated with cardiovascular disease risk factors significantly more so than is BMI (5, 25, 32, 33) . Researchers have also indicated that the WHR does not generally account for a large amount of variance in BMI compared with other measures of fat distribution, ie, waist circumference and sagittal diameter (25, 34, 35) . Apparently, the inclusion of WHR provides some additional information that is clinically useful in identifying individuals with cardiovascular disease risk factors.
Even after smoking status was stratified for, our results showed a significant odds ratio in quartile 4 for HDL, DBP, and composite risk just as in the unstratified analysis. It is important that composite risk, which indicates a clustering of cardiovascular disease risk factors, remained significantly higher in quartile 4 regardless of stratification for smoking. This was somewhat surprising because smoking has long been associated with unfavorable changes in serum lipoproteins and BP (36, 37) , and in combination with obesity, may act synergistically to increase one's risk of cardiovascular disease (15, 38, 39) . One limitation may be that smoking was not evaluated in pack-years (average number of packs of cigarettes smoked times the number of years smoked), whereas other studies showing a negative effect of smoking on cardiovascular disease risk factors and subsequent CAD used pack-years in their data analysis (15, 39) . (21) . Our results showed that stratification by either BMI or smoking did not appear to alter the general trend observed in the unstratified odds ratio analysis.
There has been some physiologic evidence to suggest an upward shift in the critical threshold for WHR in overweight women, especially with regard to resting BP (40, 41) . In overweight individuals, a higher cardiac output and expanded blood volume are necessary to meet the increased metabolic demands of greater tissue mass. If the mean arterial BP remains stable, as may occur in a healthy woman, an increase in cardiac output is associated with a decrease in vascular resistance in these individuals. In this case, for any given mean arterial pressure, cardiac output is greater and peripheral vascular resistance is lower in obese than in leaner women (42) . Perhaps, in apparently healthy, premenopausal, overweight women, a higher than expected WHR is necessary before a significant association with elevated BP or related metabolic disorders is observed. In the present study, DBP was consistently elevated in the highest WHR quartile regardless of BMI or smoking status Thus, the blanket statement that all women should reduce their WHR to < 0.80 is not entirely appropriate. Rather, a WHR approaching 0.90 in healthy but overweight women should be viewed as a red flag to alert clinicians to the possibility that these patients have cardiovascular disease risk factors and to indicate that clinicians should encourage these patients to reduce their WHR, ie, they should lose weight and exercise.
There are several limitations that should be considered when examining the results of this study. Subjects with known CAD or taking medications known to affect serum lipoproteins or BP were excluded from the study. These exclusion criteria should have reduced the likelihood of seeing significant trends in WHR in relation to cardiovascular disease risk factors. However, subjects were a heterogeneous ethnic and racial group of women, which, although representative of our city's demographics, may have affected the relation between central obesity and cardiovascular disease risk factors (43) . However, our chi-square analysis showed no significant differences in the racial/ethnic composition of the 4 quartiles. Furthermore, serum lipoprotein concentrations falling at or above the 75th percentile and at or below the 25th percentile and a BP ≥ 140/90 are conservative estimates for indicating elevated cardiovascular disease risk factors. Finally, whereas some studies have shown waist circumference to be a better index of cardiovascular disease risk factors than WHR (5, 32, 35) , others have reported WHR to be a better indicator of cardiovascular disease risk (6, 25, 44, 45) . Perry et al (34) , using a similar population of overweight women, showed no differences between waist and WHR in relation to cardiovascular disease risk factors. Given the aforementioned limitations, it appears that a WHR ≥ 0.90 may be a more specific marker for indicating elevations in cardiovascular disease risk factors in racially diverse and apparently healthy, overweight women. 
